News

Fapon Biopharma and CMAB Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset
Fapon Biopharma and CMAB Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset
The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB.
The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB.